The short version of mitochondrial biogenesis fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-12. Anything still debated is marked as such rather than presented as settled.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
| Property | Value | Notes |
|---|---|---|
| Synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
| Common form | Crystalline powder | Supplied in milligram to gram quantities |
| Long-term storage | -20 °C, desiccated, protected from light | Reduces degradation |
| Detection technique | LC-MS/MS | Common in anti-doping and research analysis |
| Regulatory status | Prohibited in sport by WADA | Not approved for human therapeutic use |
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
=== Energy === Production of oleaginous microalgae are becoming attractive as alternative sources of biofuels with potential to meet global demand for renewable bioenergy. The enhanced oil recovery (EOR) using extracellular biopolymers from microalgae may be an upcoming field of application. In recent years, EPS sugars from marine bacteria have been found to speed up the cleanup of oil spills. During the Deepwater Horizon oil spill in 2010, these EPS-producing bacteria were able to grow and multiply rapidly. It was later found that their EPS sugars dissolved the oil and formed oil aggregates on the ocean surface, which sped up the cleaning process. These oil aggregates also provided a valuable source of nutrients for other marine microbial communities. This let scientists modify and optimize the use of EPS sugars to clean up oil spills.
=== Decay by two or more processes === Some quantities decay by two exponential-decay processes simultaneously. In this case, the actual half-life T½ can be related to the half-lives t1 and t2 that the quantity would have if each of the decay processes acted in isolation:
Athletes competing in power sports, bodybuilding, professional wrestling, mixed martial arts, swimming, baseball, strength sports, track and field, cycling, soccer, weight lifting, skiing and endurance sports have been said to abuse human growth hormone, including in combination with other performance-enhancing drugs such as androgenic anabolic steroids including testosterone, certain products which claim to enhance HGH, and erythropoietin (among others). There has never been an adequately large randomized controlled trial showing definitively that HGH provides benefits to athletes and that there are no significant adverse drug reactions; there have been many small studies and several of these studies were recently reviewed and analyzed in a meta-analysis. While the authors indicated that the meta-analysis was limited by the fact that few of the included studies evaluated athletic performance and by the fact that dosing protocols in the studies may not reflect real-world doses and regimens, their conclusions were as follows:
In this way two identically sized particles can still be separated into two peaks, providing that the density is different. The limitation of the method lies in the lower limit of size which depends on the density of the sample. Specifically for biological samples, the limit is in the order of 20 to 50 nm in diameter.
For instance, cows and buffalo udders have two pairs of mammary glands and four teats, whereas sheep and goat udders have one pair of mammary glands with two teats protruding from the udder. Each mammary gland produces milk for a single teat and is evolutionarily derived from modified sweat glands.
Sources: en.wikipedia.org
As a result of population growth in African-Caribbean regions of overseas France and immigration from North and sub-Saharan Africa to mainland France, sickle cell disease has become a major health problem in France. Sickle cell disease has become the most common genetic disease in the country, with an overall birth prevalence of one in 2,415 in mainland France, ahead of phenylketonuria (one in 10,862), congenital hypothyroidism (one in 3,132), congenital adrenal hyperplasia (one in 19,008) and cystic fibrosis (one in 5,014) for the same reference period.
Kurtzer Natalia Mehlman Petrzela (2000), professor of history at The New School Fotini Christia (2001), Greek political scientist, professor at Massachusetts Institute of Technology Joya Powell (2001), Bessie Awards-winning choreographer and educator Agnia Grigas (2002), political scientist and author Cassie Mogilner Holmes (2002), professor at the UCLA Anderson School of Management Daniel Immerwahr (2002), professor of history of Northwestern University and recipient of the Merle Curti Award Jessica Chiccehitto Hindman (2003), professor at Northern Kentucky University, National Book Critics Circle Award finalist Rujeko Hockley (2005), curator of the Whitney Museum of American Art and the 2019 Whitney Biennial Susanna Berger (2007), art historian, professor at University of Southern California Ashley James (2009), first black curator of the Solomon R. Guggenheim Museum
Phlebotomies are carried out by phlebotomists – people trained to draw blood mostly from veins for clinical or medical testing, transfusions, donations, or research. Blood is collected primarily by performing venipunctures, or by using capillary blood sampling with fingersticks or a heel stick in infants for the collection of minute quantities of blood. The duties of a phlebotomist may include interpreting the tests requested, drawing blood into the correct tubes with the proper additives, accurately explaining the procedure to the person and preparing them accordingly, practicing the required forms of asepsis, practicing standard and universal precautions, restoring hemostasis of the puncture site, giving instructions on post-puncture care, affixing tubes with electronically printed labels, and delivering specimens to a laboratory. Some countries, states, or districts require that phlebotomists be licensed or registered. A therapeutic phlebotomy may be carried out in the treatment of some blood disorders (examples: hemochromatosis, polycythemia vera, porphyria cutanea tarda), and chronic hives (in research).
== Side effects == The Z-drugs are notable for producing side effects such as pronounced amnesia and more rarely hallucinations, especially when used in large doses. On rare occasions, these drugs can produce a fugue state, wherein the patient sleepwalks and may perform relatively complex actions, including cooking meals or driving cars, while effectively unconscious and with no recollection of the events upon awakening. While this effect is rare (and has also been reported to occur with some of the older sedative drugs such as temazepam and secobarbital), it can be potentially hazardous, and so further development of this class of drugs has continued in an effort to find new compounds with further improved profiles. Daytime withdrawal-related anxiety can also occur from chronic nightly nonbenzodiazepine hypnotic usage such as with zopiclone. Side effects can differ within the drug class due to differences in metabolism and pharmacology. For example, long-acting benzodiazepines have problems of drug accumulation especially in the elderly or those with liver disease, and shorter-acting benzodiazepines have a higher risk of more severe withdrawal symptoms. In the case of the nonbenzodiazepines, zaleplon may be the safest in terms of next-day sedation, and − unlike zolpidem and zopiclone − zaleplon has been found to have no association with increased motor vehicle accidents even when taken for middle-of-the-night insomnia due to its ultrashort elimination half-life.
Synthesis of pharmaceuticals, flavors and fragrances, agrochemicals, nutraceuticals, fine chemicals, bulk monomers and biofuels. Animal feed, e.g. phytase for utilization of organically bound phosphate by pigs and poultry. Food and beverage processing, e.g. lipases in cheese manufacture and laccase in wine clarification. Cosmetics, e.g. in skin care products Oils and fats processing, e.g. in biolubricants, bioemulsifiers, bio-derived emollients. Carbohydrate processing, e.g. laccase in carbohydrate oxidations. Pulp and paper, e.g. in pulp bleaching. Detergents, e.g. proteases, amylases and lipases for removal of protein, carbohydrate and fat stains. Waste water treatment, e.g. for removal of phenols, dyes, and endocrine disrupters. Biosensors/diagnostics, e.g. glucose oxidase and cholesterol oxidase biosensors. Delivery of proteins as therapeutic agents or nutritional/digestive supplements e.g. beta-galactosidase for digestive hydrolysis of lactose in dairy products to alleviate the symptoms of lactose intolerance.
Sources: en.wikipedia.org
== Preparation and use == Fruits can be dried whole (e.g., grapes, berries, apricot, plum), in halves, or as slices (e.g., mango, papaya, kiwi). Alternatively, they can be chopped after drying (e.g., dates), made into pastes, or concentrated juices. The residual moisture content can vary from small (3–8%) to substantial (16–18%), depending on the type of fruit. Fruits can also be spread out, dried and cut into strips in its puree form without the addition of sugar or fats with at least 50% moisture content as fruit leather, (see patent listed under the references section) or as a powder by spray or drum drying. They can be freeze dried. Fresh fruit is frozen and placed in a drying chamber under a vacuum. Heat is applied, and water evaporates from the fruit while it is still frozen. The fruit becomes very light and crispy and retains much of its original flavor. Dried fruit is widely used by the confectionery, baking, and sweets industries. Food manufacturing plants use dried fruits in various sauces, soups, marinades, garnishes, puddings, and food for infants and children. As ingredients in prepared food, dried fruit juices, purées, and pastes impart sensory and functional characteristics to recipes:
The 1988 US presidential elections lent new urgency to the negotiations, which had recently stalled after six consecutive rounds of talks in Brazzaville. Angola and Cuba had gambled heavily on a victory for Michael Dukakis and the Democratic Party during the US elections, hoping that this would spell the end of US aid to UNITA and a harder line on South Africa. At the time of the Geneva Protocol, dos Santos had commented that "if the Democrats had won the elections, there would be a readjustment in US policy, particularly on Southern Africa". The election of Republican candidate George H. W. Bush had the effect of persuading the Angolan and Cuban delegations to be more flexible. Crocker reiterated on several occasions that a new US administration meant changes in personnel and basic policy review, and pressed them not to waste months of effort. Three days after the US election results were released, the parties reconvened in Geneva and within the week had agreed to a phased Cuban withdrawal over the course of twenty seven months. In exchange, South Africa pledged to begin bestowing independence on South West Africa by 1 November 1989. On 13 December 1988, South Africa, Angola, and Cuba signed the Brazzaville Protocol, which affirmed their commitment to these conditions and set up a Joint Military Monitoring Commission (JMMC) to supervise the disengagement in Angola. The JMMC was to include Soviet and US observers. All hostilities between the belligerents, including PLAN, were to formally cease by 1 April 1989.
oxygen cascade The flow of oxygen from environmental sources (e.g. the air in the atmosphere) to the mitochondria of a cell, where oxygen atoms participate in biochemical reactions that result in the oxidation of energy-rich substrates such as carbohydrates in a process known as aerobic respiration.
). This diffusivity leads to a break in the magnetic topology; magnetic field lines can "reconnect" when they collide. Usually, this term is small, and reconnections can be treated as similar to shocks; this process has been shown to be important in Earth-solar magnetic interactions. Extended Extended MHD describes a class of phenomena in plasmas that are higher-order than resistive MHD, but can adequately be treated with a single-fluid description. These include the effects of Hall physics, electron pressure gradients, finite Larmor radii in the particle gyromotion, and electron inertia. Two-fluid Two-fluid MHD describes plasmas that include a non-negligible Hall electric field. As a result, the electron and ion momenta must be treated separately. This description is more closely tied to Maxwell's equations because an evolution equation for the electric field exists. Hall In 1960, M. J. Lighthill criticized the applicability of ideal or resistive MHD theory for plasmas. This concerned the neglect of the "Hall current term" in Ohm's law, a frequent simplification made in magnetic fusion theory. Hall magnetohydrodynamics (HMHD) takes into account this electric-field description of magnetohydrodynamics, and Ohm's law takes the form:
Sources: en.wikipedia.org
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.
Research-grade purity indicates a supplier's measured percentage of the intended compound. It does not guarantee safety, sterility, or suitability for human consumption. Buyers should request a certificate of analysis with chromatograms and test methods.
Sports regulators prohibit SR9009 because it is a non-approved substance with potential performance-altering effects. Its presence can be detected in anti-doping testing. Athletes are responsible for substances found in their samples.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.